Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study
ANDERSSON, Michael, LIDBRINK, Elisabeth, BERGH, Jonas, LANGKJER, Sven T, BJERRE, Karsten, WIST, Erik, ENEVOLDSEN, Kristin, JENSEN, Anders B, KARLSSON, Per, TANGE, Ulla B, SØRENSEN, Peter G, MØLLER, Susanne
Published in Journal of clinical oncology (20.01.2011)
Published in Journal of clinical oncology (20.01.2011)
Get full text
Journal Article